Quick Summary

Bitter Apricot Kernel (Prunus armeniaca) is a traditional medicinal seed primarily used in traditional Chinese medicine (TCM) formulations. Current clinical evidence stems mostly from studies on multi-herb formulas that include Bitter Apricot Kernel rather than from studies of the kernel alone. Research involving these complex herbal mixtures suggests possible benefits in managing respiratory infections, lung cancer as an adjunct therapy, mild cognitive impairment, opioid-induced constipation, and more. Reported adverse events are mainly gastrointestinal and relate to potential toxicity from excessive intake.

What Is It?

Bitter Apricot Kernel is the seed of the apricot fruit, Prunus armeniaca. It has been used medicinally in TCM and other traditional systems primarily as a component in herbal formulas. The kernel contains amygdalin, a compound associated with both therapeutic interest and toxicity concerns.

Traditional Uses

In traditional medicine, Bitter Apricot Kernel has been used for respiratory conditions such as cough and asthma, digestive complaints, and as part of herbal remedies aimed at enhancing overall vitality and immune function. It is often included in combination with other herbs rather than used in isolation.

Active Compounds

The primary active compound in Bitter Apricot Kernel is amygdalin, a cyanogenic glycoside. Other phytochemicals may contribute to its pharmacological activities, but comprehensive profiling in humans is limited.

Potential Benefits with Evidence Levels

  • Improvement of opioid-induced constipation in cancer patients: Systematic reviews and meta-analyses of randomized controlled trials (RCTs) involving traditional herbal medicine formulations likely containing Bitter Apricot Kernel show significant improvement over conventional medicines. Evidence certainty is high for total effectiveness but lower for secondary outcomes.
  • Adjunctive treatment for advanced lung adenocarcinoma: Ongoing multicenter, double-blind RCTs are investigating Chinese herbal granules combined with chemotherapy, with Bitter Apricot Kernel possibly included. These aim to assess progression-free survival and quality of life improvements.
  • Adjuvant lung cancer treatment improving response rate and reducing chemotherapy toxicity: Systematic reviews and meta-analyses suggest modified herbal formulas containing Bitter Apricot Kernel improve response rates, disease control, and patient performance scores while reducing treatment toxicity.
  • Treatment in pediatric common cold: Moderate-certainty evidence from systematic reviews and meta-analyses supports that herbal medicines including Bitter Apricot Kernel improve symptom resolution and have fewer mild gastrointestinal adverse effects compared to controls.
  • Improvement in immune function markers in non-small cell lung cancer patients: Herbal medicine formulations have been associated with increased CD4+ and CD4+/CD8+ T-cell ratios and decreased CD8+ levels, indicating possible immunomodulatory effects.
  • Potential cognitive improvement in mild cognitive impairment: Moderate-certainty evidence from RCTs indicates that Chinese herbal medicines—sometimes including Bitter Apricot Kernel—may improve cognitive function compared to placebo.
  • Antiviral adjunct in COVID-19: Multiple systematic reviews suggest that traditional Chinese medicine formulas containing Bitter Apricot Kernel may aid symptom relief, clinical recovery, and reduce progression of COVID-19, with safety comparable to conventional treatment; certainty ranges from low to moderate.

Side Effects

  • Gastrointestinal issues: diarrhea, nausea, abdominal pain
  • Neurological symptoms have been reported in safety data related to seeds including Bitter Apricot Kernel
  • Serious adverse events, including fatalities, have been reported in cases of excessive intake or misuse

Drug Interactions

There are no direct clinical data on drug interactions with isolated Bitter Apricot Kernel. However, herbal formulations containing it have been used alongside chemotherapy and conventional treatments without reports of serious interactions. Caution is advised due to the presence of amygdalin, which may have interactions with other medications.

Who Should Avoid It

  • Children, due to higher risk of adverse events
  • Pregnant and breastfeeding individuals, due to lack of safety data and potential toxicity
  • Anyone considering excessive doses or unprocessed kernels, as toxicity risk increases

Evidence Limitations

  • Most research involves multi-herb formulas rather than Bitter Apricot Kernel alone, so isolated effects remain unclear
  • Some included studies have methodological limitations such as unclear randomization, heterogeneity, and low quality
  • Safety data on isolated Bitter Apricot Kernel are limited, and toxicity concerns persist with high or improper use
  • More robust, well-designed clinical trials are needed to clarify efficacy and safety
  • Pharmacokinetics, potential drug interactions, and contraindications require further study in humans

References

Last Reviewed

June 2024

Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new herbal or health treatments, especially if you have underlying health conditions, are pregnant, breastfeeding, or taking other medications.